These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 8228729

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
    Peñalva A, Carballo A, Pombo M, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
    [Abstract] [Full Text] [Related]

  • 3. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [Abstract] [Full Text] [Related]

  • 4. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
    Cordido F, Peñalva A, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
    [Abstract] [Full Text] [Related]

  • 5. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    Peino R, Cordido F, Peñalva A, Alvarez CV, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects.
    Cordido F, Peñalva A, Peino R, Casanueva FF, Dieguez C.
    Metabolism; 1995 Jun; 44(6):745-8. PubMed ID: 7783658
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood.
    Micic D, Popovic V, Kendereski A, Macut D, Casanueva FF, Dieguez C.
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):191-4. PubMed ID: 7734029
    [Abstract] [Full Text] [Related]

  • 12. Effects of hypothyroidism, tri-iodothyronine and glucocorticoids on growth hormone responses to growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2.
    Edwards CA, Dieguez C, Scanlon MF.
    J Endocrinol; 1989 Apr; 121(1):31-6. PubMed ID: 2497223
    [Abstract] [Full Text] [Related]

  • 13. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture.
    Cheng K, Chan WW, Barreto A, Convey EM, Smith RG.
    Endocrinology; 1989 Jun; 124(6):2791-8. PubMed ID: 2541999
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non-GHRH-mediated responses.
    Malozowski S, Hao EH, Ren SG, Marin G, Liu L, Southers JL, Merriam GR.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):314-7. PubMed ID: 1856262
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging.
    Ghigo E, Arvat E, Rizzi G, Goffi S, Grottoli S, Mucci M, Boghen MF, Camanni F.
    Eur J Endocrinol; 1994 Nov; 131(5):499-503. PubMed ID: 7952160
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus.
    Villas-Boas Weffort RF, Ramos-Dias JC, Chipoch C, Lengyel AM.
    Metabolism; 1997 Jun; 46(6):706-10. PubMed ID: 9186309
    [Abstract] [Full Text] [Related]

  • 17. Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6.
    Peñalva A, Pombo M, Carballo A, Barreiro J, Casanueva FF, Dieguez C.
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):87-91. PubMed ID: 8435889
    [Abstract] [Full Text] [Related]

  • 18. Oral activity of the growth hormone releasing peptide His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in rats, dogs and monkeys.
    Walker RF, Codd EE, Barone FC, Nelson AH, Goodwin T, Campbell SA.
    Life Sci; 1990 Jan; 47(1):29-36. PubMed ID: 2117689
    [Abstract] [Full Text] [Related]

  • 19. Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion.
    Corsello SM, Tofani A, Della Casa S, Sciuto R, Rota CA, Colasanti S, Bini A, Barini A, Barbarino A.
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):113-6. PubMed ID: 1543015
    [Abstract] [Full Text] [Related]

  • 20. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
    Pombo M, Barreiro J, Peñalva A, Peino R, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.